Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG
SWB:EFF
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.348
5.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG
Deutsche Effecten & Wechsel Beteiligungs AG invests in companies, which focus on the areas of photonics and sensor systems, as well as biotechnology and information technology. The company is headquartered in Jena, Thueringen and currently employs 2 full-time employees. The company went IPO on 2010-04-29. The company concentrates on medium capitalized technology companies and supports them by equity capital, consults in corporate development and its sector network. The firm focuses its investments on companies operating primarily in the area of photonics and sensor systems. As of December 2011, the Company's portfolio consisted of Nanotron Technologies Ltd (engaged in wireless sensor networks, among others), IG Asset, Inc (engaged in the functional genome analysis), NOXXON Pharma AG (engaged in the development of pharmaceuticals on the basis of Spiegelmer technology)l, and iTAC Software (engaged in collaborative production management system for the discrete manufacturing industry). In June 2014, the Company acquired MueTec GmbH.
Deutsche Effecten & Wechsel Beteiligungs AG invests in companies, which focus on the areas of photonics and sensor systems, as well as biotechnology and information technology. The company is headquartered in Jena, Thueringen and currently employs 2 full-time employees. The company went IPO on 2010-04-29. The company concentrates on medium capitalized technology companies and supports them by equity capital, consults in corporate development and its sector network. The firm focuses its investments on companies operating primarily in the area of photonics and sensor systems. As of December 2011, the Company's portfolio consisted of Nanotron Technologies Ltd (engaged in wireless sensor networks, among others), IG Asset, Inc (engaged in the functional genome analysis), NOXXON Pharma AG (engaged in the development of pharmaceuticals on the basis of Spiegelmer technology)l, and iTAC Software (engaged in collaborative production management system for the discrete manufacturing industry). In June 2014, the Company acquired MueTec GmbH.
